{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:04:05Z","timestamp":1791353045221,"version":"4.3.1"},"reference-count":65,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2024.12701","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T07:19:50Z","timestamp":1725002390000},"source":"Crossref","is-referenced-by-count":18,"title":["Off\u2011label and unapproved pediatric drug utilization: A meta\u2011analysis"],"prefix":"10.3892","volume":"28","author":[{"given":"Xingxing","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, Heilongjiang 150006, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Gao","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuxin","family":"Yang","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Central South University, Changsha, Hunan 410078, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousman","family":"Bajinka","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Central South University, Changsha, Hunan 410078, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"key20240927091357_b1-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.therap.2018.02.002","article-title":"Off-label and unlicensed drug use in children population","volume":"73","author":"Moulis","year":"2018","journal-title":"Therapie"},{"key":"key20240927091357_b2-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.clinthera.2010.05.005","article-title":"Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: A systematic literature review","volume":"32","author":"van Riet-Nales","year":"2010","journal-title":"Clin Ther"},{"key":"key20240927091357_b3-ETM-28-5-12701","first-page":"4302","article-title":"Drug discovery and drug marketing with the critical roles of modern administration","volume":"10","author":"Chen","year":"2018","journal-title":"Am J Transl Res"},{"issue":"e016293","key":"key20240927091357_b4-ETM-28-5-12701","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016293","article-title":"Global shortage of neonatal and paediatric antibiotic trials: Rapid review","volume":"7","author":"Thompson","year":"2017","journal-title":"BMJ Open"},{"key":"key20240927091357_b5-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/bcp.12305","article-title":"Clinical trials in children","volume":"79","author":"Joseph","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"key20240927091357_b6-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/1574884712666170317161935","article-title":"Pediatric off-label and unlicensed drug use and its implications","volume":"12","author":"Gore","year":"2017","journal-title":"Curr Clin Pharmacol"},{"key":"key20240927091357_b7-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/cpt.613","article-title":"Therapeutic disasters that hastened safety testing of new drugs","volume":"101","author":"Paine","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"key20240927091357_b8-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1590\/S0104-59702020000100002","article-title":"\u2018Risk-free rest and sleep:\u2019 Jornal do M\u00e9dico (Portugal) and the thalidomide disaster, 1960-1962","volume":"27","author":"Leandro","year":"2020","journal-title":"Hist Cienc Saude Manguinhos"},{"key":"key20240927091357_b9-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1007\/s12325-018-0732-y","article-title":"Unlicensed and off-label medication use in pediatric and neonatal intensive care units: No change over a decade","volume":"35","author":"Nir-Neuman","year":"2018","journal-title":"Adv Ther"},{"issue":"e0210237","key":"key20240927091357_b10-ETM-28-5-12701","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210237","article-title":"Cross-sectional survey of off-label and unlicensed prescribing for inpatients at a paediatric teaching hospital in Western Australia","volume":"14","author":"Landwehr","year":"2019","journal-title":"PLoS One"},{"key":"key20240927091357_b11-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.euroneuro.2017.03.003","article-title":"Efficacy of off-label augmentation in unipolar depression: A systematic review of the evidence","volume":"27","author":"Kleeblatt","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"key20240927091357_b12-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/hec.3832","article-title":"Pharmaceutical expenditure and gross domestic product: Evidence of simultaneous effects using a two-step instrumental variables strategy","volume":"28","author":"Shaikh","year":"2019","journal-title":"Health Econ"},{"issue":"e021825","key":"key20240927091357_b13-ETM-28-5-12701","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021825","article-title":"Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: A retrospective review of data from the regulatory authority","volume":"8","author":"Mori","year":"2018","journal-title":"BMJ Open"},{"issue":"119905","key":"key20240927091357_b14-ETM-28-5-12701","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119905","article-title":"How can oral paediatric formulations be improved? A challenge for the XXI century","volume":"590","author":"Moreira","year":"2020","journal-title":"Int J Pharm"},{"key":"key20240927091357_b15-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"key20240927091357_b16-ETM-28-5-12701"},{"issue":"n71","key":"key20240927091357_b17-ETM-28-5-12701","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"key20240927091357_b18-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"494","DOI":"10.11124\/JBIES-22-00430","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials","volume":"21","author":"Barker","year":"2023","journal-title":"JBI Evid Synth"},{"key":"key20240927091357_b19-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/08035259950168469","article-title":"Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: A prospective study","volume":"88","author":"Turner","year":"1999","journal-title":"Acta Paediatr"},{"key":"key20240927091357_b20-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"F142","DOI":"10.1136\/fn.80.2.f142","article-title":"Unlicensed and off label drug use in neonates","volume":"80","author":"Conroy","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"key20240927091357_b21-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/08035250252834030","article-title":"Off-label use of drugs in Italy: A prospective, observational and multicentre study","volume":"91","author":"Pandofini","year":"2002","journal-title":"Acta Paediatr"},{"key":"key20240927091357_b22-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1055\/s-2002-23557","article-title":"Unlicensed and off-label medication use in a neonatal intensive care unit: A prospective study","volume":"19","author":"Barr","year":"2002","journal-title":"Am J Perinatol"},{"key":"key20240927091357_b23-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00228-002-0479-9","article-title":"Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands","volume":"58","author":"Jong","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"key20240927091357_b24-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/annonc\/mdg031","article-title":"Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in children","volume":"14","author":"Conroy","year":"2003","journal-title":"Ann Oncol"},{"key":"key20240927091357_b25-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1183\/09031936.04.00015404","article-title":"Unlicensed and off-label prescription of respiratory drugs to children","volume":"23","author":"Jong","year":"2004","journal-title":"Eur Respir J"},{"key":"key20240927091357_b26-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2165\/00002018-200427130-00006","article-title":"The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients","volume":"27","author":"Neubert","year":"2004","journal-title":"Drug Saf"},{"key":"key20240927091357_b27-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00228-005-0981-y","article-title":"Off label and unlicensed drugs use in paediatric cardiology","volume":"61","author":"Bajcetic","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"key20240927091357_b28-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4414\/smw.2006.11275","article-title":"Unlicensed and off-label drug use in a Swiss paediatric university hospital","volume":"136","author":"Di Paolo","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"key20240927091357_b29-ETM-28-5-12701","first-page":"3","article-title":"An assessment of the extent of use of off-license and unlicensed drugs on children at Parirenyatwa Hospital in Harare, Zimbabwe","volume":"9","author":"Kaisi","year":"2007","journal-title":"East Cent Afr J Pharm Sci"},{"key":"key20240927091357_b30-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00228-008-0543-1","article-title":"Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil","volume":"64","author":"Santos","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"key20240927091357_b31-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s12098-009-0238-3","article-title":"Off-label drug use in a pediatric intensive care unit","volume":"76","author":"Bavdekar","year":"2009","journal-title":"Indian J Pediatr"},{"key":"key20240927091357_b32-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00228-011-1072-x","article-title":"Drug utilisation pattern and off-label use of medicines in Estonian neonatal units","volume":"67","author":"Lass","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"key20240927091357_b33-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00228-012-1221-x","article-title":"Unlicensed and off-label drug use in hospitalized children in Croatia: A cross-sectional survey","volume":"68","author":"Pal\u010devski","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"key20240927091357_b34-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11096-011-9604-0","article-title":"Off-label and unlicensed drug use in neonatal intensive care units in Turkey: The old-inn study","volume":"34","author":"Oguz","year":"2012","journal-title":"Int J Clin Pharm"},{"key":"key20240927091357_b35-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/jpc.12065","article-title":"Off-label use of medicines in paediatric inpatients at an Australian teaching hospital","volume":"49","author":"Ballard","year":"2013","journal-title":"J Paediatr Child Health"},{"key":"key20240927091357_b36-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1111\/apa.12541","article-title":"Unlicensed and off-label drug use in an Irish neonatal intensive care unit: A prospective cohort study","volume":"103","author":"Kieran","year":"2014","journal-title":"Acta Paediatr"},{"key":"key20240927091357_b37-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"297","DOI":"10.20344\/amp.5271","article-title":"Off-label and unlicensed drug use in neonatology: Reality in a Portuguese University Hospital","volume":"28","author":"Silva","year":"2015","journal-title":"Acta Med Port"},{"key":"key20240927091357_b38-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s11096-013-9846-0","article-title":"Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia","volume":"35","author":"Lee","year":"2013","journal-title":"Int J Clin Pharm"},{"key":"key20240927091357_b39-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11096-012-9699-y","article-title":"Off-label drug prescribing in a Portuguese paediatric emergency unit","volume":"35","author":"Ribeiro","year":"2013","journal-title":"Int J Clin Pharm"},{"key":"key20240927091357_b40-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/jcpt.12119","article-title":"Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric regulation","volume":"39","author":"Lindell-Osuagwu","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"key20240927091357_b41-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/ped.12190","article-title":"Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy","volume":"56","author":"Laforgia","year":"2014","journal-title":"Pediatr Int"},{"issue":"12","key":"key20240927091357_b42-ETM-28-5-12701","doi-asserted-by":"publisher","DOI":"10.1186\/1824-7288-40-12","article-title":"Incidence of unlicensed and off-label prescription in children","volume":"40","author":"Langerov\u00e1","year":"2014","journal-title":"Ital J Pediatr"},{"key":"key20240927091357_b43-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5863\/1551-6776-19.4.296","article-title":"Evaluation of off-label prescribing at a children's rehabilitation center","volume":"19","author":"Luedtke","year":"2014","journal-title":"J Pediatr Pharmacol Ther"},{"key":"key20240927091357_b44-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1111\/apa.12924","article-title":"Unlicensed and off-label drug use: A prospective study in French NICU","volume":"104","author":"Riou","year":"2015","journal-title":"Acta Paediatr"},{"key":"key20240927091357_b45-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1007\/s11096-015-0191-3","article-title":"Off-label and unlicensed utilisation of medicines in a French paediatric hospital","volume":"37","author":"Joret-Descout","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"key20240927091357_b46-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3233\/JRS-150653","article-title":"Off-label and unlicensed drug use in children admitted to pediatric intensive care units (PICU)","volume":"27","author":"Jobanputra","year":"2015","journal-title":"Int J Risk Saf Med"},{"key":"key20240927091357_b47-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.clinthera.2016.06.009","article-title":"Comparative assessment of off-label and unlicensed drug prescriptions in children: FDA versus ANSM guidelines","volume":"38","author":"Berdkan","year":"2016","journal-title":"Clin Ther"},{"key":"key20240927091357_b48-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00228-015-1962-4","article-title":"Off-label and unlicensed drug treatments in neonatal intensive care units: An Italian multicentre study","volume":"72","author":"Cuzzolin","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"key20240927091357_b49-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/pch\/21.2.83","article-title":"Unlicensed and off-label drug use in paediatrics in a mother-child tertiary care hospital","volume":"21","author":"Corny","year":"2016","journal-title":"Paediatr Child Health"},{"key":"key20240927091357_b50-ETM-28-5-12701","doi-asserted-by":"crossref","first-page":"355","DOI":"10.22159\/ajpcr.2017.v10i1.15477","article-title":"Off-label and unlicensed prescribing in pediatric inpatients with nephrotic syndrome in a major teaching hospital: An Indonesian context","volume":"10","author":"Ramadaniati","year":"2017","journal-title":"Asian J Pharm Clin Res"},{"issue":"e00304","key":"key20240927091357_b51-ETM-28-5-12701","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.304","article-title":"Off-label drug use in hospitalized children: A prospective observational study at Gondar University Referral Hospital, Northwestern Ethiopia","volume":"5","author":"Tefera","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"key20240927091357_b52-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/jphp.12581","article-title":"Off-label and unlicensed medicines to hospitalised children in Norway","volume":"69","author":"Teigen","year":"2017","journal-title":"J Pharm Pharmacol"},{"issue":"e0204427","key":"key20240927091357_b53-ETM-28-5-12701","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204427","article-title":"Use of off-label and unlicensed medicines in neonatal intensive care","volume":"13","author":"Costa","year":"2018","journal-title":"PLoS One"},{"key":"key20240927091357_b54-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s11096-018-0630-z","article-title":"Off-label and unlicensed drug use in hospitalized newborns in a Saudi tertiary care hospital: A cohort study","volume":"40","author":"Mazhar","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"242","key":"key20240927091357_b55-ETM-28-5-12701","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-018-1211-y","article-title":"Drug utilization in neonatal setting of Pakistan: Focus on unlicensed and off label drug prescribing","volume":"18","author":"Aamir","year":"2018","journal-title":"BMC Pediatr"},{"key":"key20240927091357_b56-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2174\/1573396314666181113101506","article-title":"The unlicensed and off-label prescription of medications in general paediatric ward: An observational study","volume":"15","author":"Dornelles","year":"2019","journal-title":"Curr Pediatr Rev"},{"issue":"3","key":"key20240927091357_b57-ETM-28-5-12701","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-018-1370-x","article-title":"Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran","volume":"19","author":"Kouti","year":"2019","journal-title":"BMC Pediatr"},{"issue":"e0227687","key":"key20240927091357_b58-ETM-28-5-12701","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227687","article-title":"High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.-Oct. 2014","volume":"15","author":"Tukayo","year":"2020","journal-title":"PLoS One"},{"issue":"41","key":"key20240927091357_b59-ETM-28-5-12701","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-020-0809-5","article-title":"Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit","volume":"46","author":"Gidey","year":"2020","journal-title":"Ital J Pediatr"},{"key":"key20240927091357_b60-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jpainsymman.2020.06.014","article-title":"Off-label and unlicensed drugs in pediatric palliative care: A prospective observational study","volume":"60","author":"Garc\u00eda-L\u00f3pez","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"key20240927091357_b61-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/0018578720942226","article-title":"Off-Label drug use in pediatric out-patient care: A multi-center observational study","volume":"56","author":"AlAzmi","year":"2021","journal-title":"Hosp Pharm"},{"key":"key20240927091357_b62-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.clinthera.2016.01.012","article-title":"Improvement of pediatric drug development: Regulatory and practical frameworks","volume":"38","author":"Tsukamoto","year":"2016","journal-title":"Clin Ther"},{"key":"key20240927091357_b63-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/IPRP.S231134","article-title":"Exploratory findings of prescribing unlicensed and off-label medicines among children and neonates","volume":"9","author":"Shakeel","year":"2020","journal-title":"Integr Pharm Res Pract"},{"key":"key20240927091357_b64-ETM-28-5-12701","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/jebm.12402","article-title":"Unlicensed and off-label prescription of drugs to children in primary health care: A systematic review","volume":"13","author":"Andrade","year":"2020","journal-title":"J Evid Based Med"},{"key":"key20240927091357_b65-ETM-28-5-12701","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(96)91182-4","article-title":"Use of \u2018off-label\u2019 and unlicensed drugs in paediatric intensive care unit","volume":"347","author":"Turner","year":"1996","journal-title":"Lancet"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T02:14:05Z","timestamp":1727403245000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2024.12701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":65,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,8,30]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2024.12701","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"article-number":"412"}}